Kovitz Investment Group Partners, LLC Bristol Myers Squibb CO Call Options Transaction History

Kovitz Investment Group Partners, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Apr 22, 2022	BUY	$61.48 - $73.72 $16,415 - $19,683	267 Added 14.78%	2,074 $525,000
Q4 2021 Feb 04, 2022	BUY	$53.63 - $62.52 $70,201 - $81,838	1,309 Added 262.85%	1,807 $687,000
Q3 2021 Oct 28, 2021	BUY	$59.17 - $69.31 $295 - $346	5 Added 1.01%	498 $488,000
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $619 - $674	10 Added 2.07%	493 $789,000
Q1 2021 May 06, 2021	BUY	$59.34 - $66.74 $4,153 - $4,671	70 Added 16.95%	483 $661,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $519 - $588	9 Added 2.23%	413 $555,000
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $746 - $827	13 Added 3.32%	404 $498,000
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $9,209 - $10,767	168 Added 75.34%	391 $472,000
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $10,347 - $15,036	223 New	223 $300,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kovitz Investment Group Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Kovitz Investment Group Partners, LLC with notifications on news.